Yaws eradication

Accelerating yaws eradication: antibiotic added to WHO’s essential medicines list

© WHO

9 June 2017 | Geneva –– The World Health Organization (WHO) has indicated azithromycin as the antibiotic for the treatment of yaws - a chronic infectious disease that mainly affects children.

Its inclusion in WHO's latest Model list of Essential Medicines is expected to facilitate access to the medicine and enhance the implementation its eradication, worldwide.

Indonesia mobilizes resources to defeat yaws

© WHO

19 May 2017 | Geneva -- Indonesia has rolled out a comprehensive programme to eliminate yaws - a chronic skin disease that mainly affects children.

Strong political commitment has ensured adequate funding for the programme and the procurement of azithromycin - an oral antibiotic that can cure yaws infection.

Yaws is the third disease targeted for eradication by the World Health Organization (WHO). The two others are: dracunculiasis (guinea-worm disease) and polio.

Brazil’s EMS pledges medicine donation to accelerate yaws eradication

Carlos Sanchez, Chairman of the Board of Directors of the NC Group
© WHO

19 April 2017 |Geneva –– Brazil’s largest pharmaceutical company, EMS has announced the donation of the oral form of the antibiotic azithromycin to support a renewed initiative by the World Health Organization (WHO) to achieve the eradication of yaws by 2020.
Until recently, the standard treatment for yaws has been intramuscular injections of benzathine penicillin. The discovery in 2012 that a single oral dose of azithromycin completely cures the disease can accelerate the eradication of the disease.
The researcher who discovered that a single dose of oral azithromycin against yaws recently appealed for free donation of tablets to accelerate eradication of the disease.

WHO leads multi-country study to simplify oral treatment of yaws

© National Yaws Eradication Programme
Health workers using rapid point-of-care tests during a yaws study in Ghana

29 July 2016 | Geneva –– A study in Ghana and Papua New Guinea will determine if a lower dose of the antibiotic, azithromycin, is effective in curing yaws - a chronic skin disease that mainly affects children.
A lower dose is currently being used to treat trachoma, a disease of the eye. If efficacy of a yaws low dose is established, it can be a win-win situation to simultaneously tackle both diseases of poverty.
The researcher who discovered that a single dose of oral azithromycin against yaws recently appealed for free donation of tablets to accelerate eradication of the disease.

Photo galleries


Learn about the disease


Videos

− You are watching :
"Global eradication of yaws is feasible by 2020"

Contacts

Yaws Eradication Programme:
yaws@who.int


Media contact:
Ashok Moloo
molooa@who.int
+41 22 791 1637
+41 79 540 50 86 (mobile)